Cholesterol Drug Recalled by Merck

Tuesday, 14 Jan 2014 05:38 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
Packaging defects have prompted a recall of a combination cholesterol drug called Liptruzet, produced by Merck & Co., temporarily affecting the entire U.S. stock.

Merck said the foil pouches holding Liptruzet pills could allow air and moisture inside, potentially decreasing the drug's effectiveness.

The recall covers all four dose strengths and every batch that's gone out since Liptruzet hit the market in May.

Editor's note: No. 1 Best-Seller: A Revolutionary Heart-Disease Cure

Liptruzet combines two medications that work together to reduce "bad" cholesterol levels:
  • Atorvastatin, the generic version of the widely used cholesterol medication Lipitor, which reduces the body's natural cholesterol production, and
  • Zetia (ezetimibe), a Merck-produced drug that decreases the amount of cholesterol absorbed from food.
Cardiologists expect no health problems to result from the recall, in part because both atorvastatin and Zetia will remain available separately.

"Patients are not going to be in any harm's way just going on atorvastatin until this packaging issue gets corrected," said Dr. Kevin Marzo, chief of cardiology at Winthrop-University Hospital in Mineola, N.Y.

Marzo added that since the drug has been out for just a matter of months, it's unlikely that doctors have been prescribing it widely.

If a doctor feels a patient needs the combination treatment, then the doctor can prescribe both drugs individually and the patient can take two pills, said Dr. Deepak Bhatt, executive director of Interventional Cardiovascular Programs at Brigham and Women's Hospital Heart and Vascular Center, in Boston.

Patients can continue to take any Liptruzet they already have on hand, according to Merck, and should talk with their doctor before they quit taking it.

Bhatt said the real risk of this recall is that patients will hear about it and stop taking their cholesterol medication altogether.

"It should be relatively simple and even cheaper to substitute atorvastatin," Bhatt said. "Bottom line, this is something that can be addressed in a relatively straightforward way.
The key is not to say, 'Well, I don't have to take anything in its place.'"

Liptruzet and Zetia each cost more than $5.50 per pill, while atorvastatin costs about a quarter per pill.

Merck said it plans to get Liptruzet back on the market as soon as possible.

Editor's note: No. 1 Best-Seller: A Revolutionary Heart-Disease Cure

© HealthDay

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
You May Also Like

Heavy Drinking Can Lead to Late-in-Life Memory Problems: Study

Wednesday, 30 Jul 2014 12:32 PM

Middle-aged adults with a history of alcohol abuse are more than twice as likely as others to develop severe memory prob . . .

Gardens Soothe Agitation in Those With Dementia: Study

Wednesday, 30 Jul 2014 12:29 PM

Spending time in a garden might help soothe the agitation that commonly strikes people with dementia, a new review sugge . . .

Blood Test May Predict Suicide Risk

Wednesday, 30 Jul 2014 12:17 PM

A gene tied to negative thoughts and impulses may lead to a blood test predicting suicide risk, according to researchers . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved